Levofloxacin Injection, Solution
NDC Package 0143-9721-24
Package Information
Levofloxacin injection is levofloxacin is used to treat a variety of bacterial infections. This formulation utilizes a injection, solution delivery system. Marketed by Hikma Pharmaceuticals Usa Inc., this product is identified by NDC 0143-9721 and is authorized under FDA application ANDA091375.
Identification & Billing
- RxCUI: 1665497 - levoFLOXacin 250 MG in 50 ML Injection
- RxCUI: 1665497 - 50 ML levofloxacin 5 MG/ML Injection
- RxCUI: 1665497 - levofloxacin 250 MG per 50 ML Injection
- RxCUI: 1665507 - levoFLOXacin 500 MG in 100 ML Injection
- RxCUI: 1665507 - 100 ML levofloxacin 5 MG/ML Injection
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0143 - Hikma Pharmaceuticals Usa Inc.
- 0143-9721 - Levofloxacin
- 0143-9721-24 - 24 BAG in 1 CARTON / 100 mL in 1 BAG (0143-9721-01)
- 0143-9721 - Levofloxacin
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0143-9721-24 identifies a specific commercial package of 24 bag in 1 carton / 100 ml in 1 bag (0143-9721-01) of Levofloxacin, a human prescription drug labeled by Hikma Pharmaceuticals Usa Inc.. This injection, solution is formulated for intravenous use and contains levofloxacin as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Hikma Pharmaceuticals Usa Inc. on September 16, 2011. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
Levofloxacin is used to treat a variety of bacterial infections. This medication belongs to a class of drugs known as quinolone antibiotics. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections.
How is this Hikma Pharmaceuticals Usa Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00143972124. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.